Table 1.
Patient characteristics of women participating in this study. Data presented as mean ± standard deviation (SD) or median with interquartile range (IQR), as appropriate, or numbers (%).
| COVID-19 during Pregnancy (n = 23) |
Healthy Controls (n = 46) |
p-Value | |
|---|---|---|---|
| Maternal age, years (IQR) | 32.2 (28.8–35.7) | 31.9 (29.3–35.6) | 0.932 |
| Maternal BMI, kg/m2 | 24.7 (23.5–33.6) | 24.1 (21.9–26.9) | 0.268 |
| Gestational age at hemodynamic measurement, weeks ± SD | 25.5 ± 5.6 | 24.0 ± 5.9 | 0.324 |
| Nulliparous, n (%) | 11 (47.83%) | 23 (50.0%) | 0.865 |
| Mode of conception | 0.123 | ||
| Spontaneous, n (%) | 20 (87.0%) | 44 (95.7%) | |
| In vitro fertilization, n (%) | 1 (4.3%) | 2 (4.3%) | |
| Intracytoplasmic sperm injection (%) | 2 (8.7%) | 0 (0.0%) | |
| Cardiovascular disease, n (%) | 2 (8.7%) | 0 (0.0%) | 0.042 |
| Lung disease, n (%) | 1 (4.3%) | 0 (0.0%) | 0.154 |
| Diabetes, n (%) | 1 (4.3%) | 0 (0.0%) | 0.154 |
| Hematological disease, n (%) | 0 (0.0%) | 0 (0.0%) | - |
| Liver disease, n (%) | 0 (0.0%) | 0 (0.0%) | - |
| Endocrinological disease, n (%) | 2 (8.7%) | 0 (0.0%) | 0.042 |
| Neurological disease, n (%) | 2 (8.7%) | 0 (0.0%) | 0.042 |
| Renal disease, n (%) | 1 (4.3%) | 0 (0.0%) | 0.154 |
| Smoking during pregnancy | 0 (0.0%) | 1 (3.0%) | 0.400 |